Gregory Allen

1

Article

0

Comments
Killer T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). NICHD/J. Lippincott-Schwartz

Anti‑cancer CAR‑T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target

Gregory Allen, University of California, San Francisco

Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.

Contact Gregory for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision
  • Location: San Francisco, California, U.S.
  • Article Feed
  • Joined